These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
125 related articles for article (PubMed ID: 7274047)
1. The cut finger syndrome--Intercept vaginal suppositories. Ponte CD Drug Intell Clin Pharm; 1981 Apr; 15(4):292. PubMed ID: 7274047 [No Abstract] [Full Text] [Related]
2. Evaluation of a new vaginal contraceptive. Stone SC; Cardinale F Am J Obstet Gynecol; 1979 Mar; 133(6):635-8. PubMed ID: 233541 [TBL] [Abstract][Full Text] [Related]
3. Severe chemical cystitis from the transurethral intravesical insertion of a vaginal contraceptive suppository: a report of 3 cases and proposed method of management. Mayersak JS; Viviano CJ J Urol; 1993 Apr; 149(4):835-7. PubMed ID: 8384272 [TBL] [Abstract][Full Text] [Related]
4. Nonprescription vaginal contraception. Edelman DA Int J Gynaecol Obstet; 1980; 18(5):340-4. PubMed ID: 6110578 [TBL] [Abstract][Full Text] [Related]
5. A retrospective clinical study of a vaginal contraceptive suppository. Squire JJ; Berger GS; Keith L J Reprod Med; 1979 Jun; 22(6):319-23. PubMed ID: 469867 [No Abstract] [Full Text] [Related]
6. Counsel spermicide users to follow instructions for success. Reese M Hatcher RA Contracept Technol Update; 1985 Mar; 6(3):48-9. PubMed ID: 12266721 [TBL] [Abstract][Full Text] [Related]
7. Instruct patients to follow directions for proper use of vaginal spermicides. Hatcher RA; Reese M Contracept Technol Update; 1984 Dec; 5(12):157. PubMed ID: 12339713 [TBL] [Abstract][Full Text] [Related]
8. An user acceptability study of vaginal spermicides in combination with barrier methods or an IUCD. Black C; Houghton VP Contraception; 1983 Aug; 28(2):103-10. PubMed ID: 6641219 [TBL] [Abstract][Full Text] [Related]
9. Contraceptive effectiveness and safety of five nonoxynol-9 spermicides: a randomized trial. Raymond EG; Chen PL; Luoto J; Obstet Gynecol; 2004 Mar; 103(3):430-9. PubMed ID: 14990402 [TBL] [Abstract][Full Text] [Related]
10. Barrier and spermicidal contraceptive methods and risk of invasive cervical cancer. Hildesheim A; Brinton LA; Mallin K; Lehman HF; Stolley P; Savitz DA; Levine R Epidemiology; 1990 Jul; 1(4):266-72. PubMed ID: 2083303 [TBL] [Abstract][Full Text] [Related]
11. An evaluation of the amount of nonoxynol-9 remaining in the vagina up to 4 h after insertion of a vaginal contraceptive film (VCF) containing 70 mg nonoxynol-9. Mauck CK; Allen S; Baker JM; Barr SP; Abercrombie T; Archer DF Contraception; 1997 Aug; 56(2):103-10. PubMed ID: 9315419 [TBL] [Abstract][Full Text] [Related]
17. Termination of early gestation with 9-deoxo-16,16-dimethyl-9-methylene prostaglandin E2. Brenner PF; Marrs RP; Roy S; Mishell DR Contraception; 1982 Sep; 26(3):261-77. PubMed ID: 6184197 [TBL] [Abstract][Full Text] [Related]
18. [Trial of a new spermatocidal agent in suppository form with local disinfectant action]. Orzi C; Mazzilli F; Tellini P Minerva Ginecol; 1981 Jan; 33(1):113-6. PubMed ID: 6787483 [TBL] [Abstract][Full Text] [Related]